The ACP reviewed relevant studies but came to conclusions 'not germane to the way we treat patients with type 2 diabetes today,' says Dr Anne Peters.

Dr Kuchay discusses his findings from the E-LIFT study.

A new Medicare benefit can help patients prevent diabetes and improve other aspects of their health, says Dr Anne Peters.

Dr Peters clarifies the pros and cons of the Dexcom and FreeStyle Libre continuous glucose monitors for patients with diabetes.

Drs Shubrook and Chamberlain discuss cardiovascular risk reduction associated with SGLT-2 inhibitors and GLP-1 agonists in T2D, and advise clinicians to 'be aware.'

Dr JoAnn Manson offers clinicians a new resource to guide discussions with patients about vitamins and supplements.

An effort to encourage individualized treatment choices may muddy the therapy waters, says Dr Peters.

Dr Tyree Winters stresses the importance of identifying at-risk kids and screening often, as much as annually, to be sure that early-stage type 2 diabetes is not missed.

Dr Alan Jacobs reports on a recent study suggesting that antihypertensive therapy might not return microcirculation to normal.

Drs O'Donoghue and McGuire discuss the data on the various SGLT2 inhibitors and GLP1 receptor agonists and when to consider prescribing them to your patients with diabetes.